Some scientists believe that we’re in the golden age of biotechnology. Scientific advances are creating new and previously only imaginable ways to treat and prevent diseases. The biotech sector ...

PDS BIOTECHNOLOGY ($PDSB) posted quarterly earnings results on Thursday, March 27th. The company reported earnings of -$0.21 per share, beating estimates of -$0.28 by ...

Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance. Its lead product is the Veto Cell immune system management ...

Global diagnostic company, Anbio Biotechnology (NNNN ... 2025 under the ticker symbol “NNNN.” The company expects to receive aggregate gross proceeds of $8M. The offering is expected to ...

Detailed price information for Resverlogix Corp (RVX-T) from The Globe and Mail including charting and trades.

Detailed price information for Xortx Therapeutics Inc (XRTX-X) from The Globe and Mail including charting and trades.